HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases

Leukemia

Volumn 10, Issue 9, 1996, Pages 1520-1526

  Ries, C ^a,b   Lottspeich, F ^c   Dittmann, K H ^b   Petrides, P E ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Cell invasion and metastasis; HL 60; Leukemia; Matrix metalloproteinases; Tissue inhibitor of metalloproteinases

Indexed keywords

GELATINASE B; MUTANT PROTEIN; ORGANOMERCURY COMPOUND; PHORBOL ESTER; TISSUE INHIBITOR OF METALLOPROTEINASE; TRYPSIN;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOREGULATION; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0029761280     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Freireich EJ. Acute leukemia: a prototype of a disseminated cancer. Cancer 1984; 53: 2026-2032.
2. Woessner JFJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-2154.
3. Stetler-Stevenson WG, Liotta LA, Kleiner DEJ. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993; 7: 1434-1441.
4. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995; 376: 345-355.
5. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7: 77-83.
6. Liotta LA, Steeg PS, Stetler Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-336.
7. French DL, Ramos-DeSimone N, Rozinski K, Nuovo GJ. Matrix metalloproteinase-9 in tumor cell invasion. In: Greenwald RA, Golub LM (eds). Inhibition of Matrix Metalloproteinases: Therapeutic Potential. The New York Academy of Sciences: New York, 1994, pp 324-334.
8. Bernhard EJ, Gruber SB, Muschel RJ. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 1994; 91: 4293-4297.
9. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990; 82: 589-595.
10. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989; 243: 947-950.
11. Petrides PE, Dittmann KH. How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles. Ann Hematol (Blut) 1990; 61: 3-13.
12. Doherty NS, Janusz MJ. Neutrophil proteases: their physiological and pathological roles. In: Hellewell PG, Williams TJ (eds). Immunopharmacology of Neutrophils. Academic Press: London, 1994, pp 55-94.
13. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg GI. Natural metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest 1990; 86: 1496-1502.
14. Ries C, Kolb H, Petrides PE. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 1994; 83: 3638-3646.
15. Görg A, Postel W, Westermeier R, Gianazza E, Righetti PG. Gel gradient electrophoresis, isoelectric focusing, and two-dimensional techniques in horizontal ultrathin polyacrylamide layers. J Biochem Biophys Meth 1980; 3: 273-284.
16. Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of the staining. Electrophoresis 1985; 6: 103-112.
17. Dean DD, Martel Pelletier J, Pelletier JP, Howell DS, Woessner JFJ. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989; 84: 678-685.
18. Eckerskorn C, Mewes W, Goretzki H, Lottspeich F. A new siliconized-glass fiber as support for protein-chemical analysis of electroblotted proteins. Eur J Biochem 1988; 176: 509-519.
19. Salo T, Liotta LA, Trygvason K. Purification and characterization of murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. J Biol Chem 1983; 258: 3058-3063.
20. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213-17221.
21. Davis GE, Martin BM. A latent Mr 94 000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes. Cancer Res 1990; 50: 1113-1120.
22. Moll UM, Youngleib GL, Rosinski KB, Quigley JP. Tumor promoter-stimulated Mr 92 000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 1990; 50: 6162-6170.
23. Opdenakker G, Masure S, Proost P, Billiau A, van Damme J. Natural human monocyte gelatinase and its inhibitor. FEBS Lett 1991; 284: 73-78.
24. Kjeldsen L, Bjerrum OW, Hovgaard D, Johnsen AH, Sehested M, Borregaard N. Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. Eur J Haematol 1992; 49: 180-191.
25. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M. Purification and characterization of matrix metalloproteinase 9 from monocytic leukaemia and HT 1080 fibrosarcoma cells. Biochem J 1992; 285: 603-611.
26. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 1992; 267: 21712-21719.
27. Triebel S, Bläser J, Reinke H, Knäuper V, Tschesche H. Mercurial activation of human PMN leucocyte type IV procollagenase (gelatinase). FEBS Lett 1992; 298: 280-284.
28. Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 1993; 32: 4330-4337.
29. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267: 4583-4591.
30. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJ. The C-terminal domain of 72-kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 1992; 283: 637-641.
31. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318: 66-69.